CT-P13 subcutaneous infliximab in gastroenterology and rheumatology

D Casey is an employee of Celltrion Healthcare. M Perry has received advisory board and speakers fees from Celltrion. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif